
Ganapathy Krishnan
Examiner (ID: 18545)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1654 |
| Issued Applications | 795 |
| Pending Applications | 189 |
| Abandoned Applications | 704 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20179730
[patent_doc_number] => 20250263688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => METHOD FOR ISOLATING HIGHLY PURE NUCLEIC ACID WITH MAGNETIC PARTICLES
[patent_app_type] => utility
[patent_app_number] => 19/196130
[patent_app_country] => US
[patent_app_date] => 2025-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19196130
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/196130 | METHOD FOR ISOLATING HIGHLY PURE NUCLEIC ACID WITH MAGNETIC PARTICLES | Apr 30, 2025 | Pending |
Array
(
[id] => 20320101
[patent_doc_number] => 20250332189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => RIBOSE-MODIFIED CAP ANALOG AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/066352
[patent_app_country] => US
[patent_app_date] => 2025-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19066352
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/066352 | RIBOSE-MODIFIED CAP ANALOG AND USE THEREOF | Feb 27, 2025 | Pending |
Array
(
[id] => 19845093
[patent_doc_number] => 20250090444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => COMPOSITION FOR MAKEUP REMOVAL AND METHODS FOR PREPARING, PACKAGING, AND USING SAME, AND MAKEUP REMOVING GEL
[patent_app_type] => utility
[patent_app_number] => 18/930999
[patent_app_country] => US
[patent_app_date] => 2024-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18930999
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/930999 | Composition for makeup removal and methods for preparing, packaging, and using same, and makeup removing gel | Oct 28, 2024 | Issued |
Array
(
[id] => 19754718
[patent_doc_number] => 20250043283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS VIA FAST-FLOW SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/749007
[patent_app_country] => US
[patent_app_date] => 2024-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 552
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18749007
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/749007 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS VIA FAST-FLOW SYNTHESIS | Jun 19, 2024 | Pending |
Array
(
[id] => 20106950
[patent_doc_number] => 12357648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Injectable antibiotic formulations and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/652718
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652718 | Injectable antibiotic formulations and use thereof | Apr 30, 2024 | Issued |
Array
(
[id] => 19512065
[patent_doc_number] => 20240343751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => METHOD FOR PRODUCING D-ALLULOSE CRYSTALS
[patent_app_type] => utility
[patent_app_number] => 18/593522
[patent_app_country] => US
[patent_app_date] => 2024-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18593522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/593522 | METHOD FOR PRODUCING D-ALLULOSE CRYSTALS | Feb 29, 2024 | Pending |
Array
(
[id] => 19401994
[patent_doc_number] => 20240285505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => BODY MILK
[patent_app_type] => utility
[patent_app_number] => 18/443653
[patent_app_country] => US
[patent_app_date] => 2024-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18443653
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/443653 | BODY MILK | Feb 15, 2024 | Pending |
Array
(
[id] => 19682342
[patent_doc_number] => 20250000887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/433651
[patent_app_country] => US
[patent_app_date] => 2024-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18433651
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/433651 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | Feb 5, 2024 | Abandoned |
Array
(
[id] => 19682342
[patent_doc_number] => 20250000887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/433651
[patent_app_country] => US
[patent_app_date] => 2024-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18433651
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/433651 | COMPOSITIONS COMPRISING 2'-DEOXYCYTIDINE ANALOGS AND USE THEREOF FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA, AND CANCERS | Feb 5, 2024 | Abandoned |
Array
(
[id] => 19682348
[patent_doc_number] => 20250000893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => METHODS FOR TREATMENT OR PREVENTION OF DAMAGE RESULTING FROM RADIATION, TRAUMA OR SHOCK
[patent_app_type] => utility
[patent_app_number] => 18/430984
[patent_app_country] => US
[patent_app_date] => 2024-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18430984
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/430984 | METHODS FOR TREATMENT OR PREVENTION OF DAMAGE RESULTING FROM RADIATION, TRAUMA OR SHOCK | Feb 1, 2024 | Pending |
Array
(
[id] => 19248686
[patent_doc_number] => 20240199673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Process For Purifying Sialylated Oligosaccharides
[patent_app_type] => utility
[patent_app_number] => 18/417034
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417034
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417034 | Process For Purifying Sialylated Oligosaccharides | Jan 18, 2024 | Pending |
Array
(
[id] => 19203060
[patent_doc_number] => 20240174959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => NOVEL POLYMER-COATED CROSSLINKED ALGINATE GEL FIBER
[patent_app_type] => utility
[patent_app_number] => 18/392583
[patent_app_country] => US
[patent_app_date] => 2023-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18392583
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/392583 | Polymer-coated crosslinked alginate gel fiber | Dec 20, 2023 | Issued |
Array
(
[id] => 19032470
[patent_doc_number] => 20240082285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => APPLICATION OF CHEBULINIC ACID IN PREPARATION OF ANTI-ROTAVIRUS DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/510757
[patent_app_country] => US
[patent_app_date] => 2023-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18510757
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/510757 | APPLICATION OF CHEBULINIC ACID IN PREPARATION OF ANTI-ROTAVIRUS DRUGS | Nov 15, 2023 | Abandoned |
Array
(
[id] => 19032468
[patent_doc_number] => 20240082283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => METHODS OF TREATING DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/506167
[patent_app_country] => US
[patent_app_date] => 2023-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/506167 | METHODS OF TREATING DISEASES | Nov 9, 2023 | Abandoned |
Array
(
[id] => 19127180
[patent_doc_number] => 20240132533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/499248
[patent_app_country] => US
[patent_app_date] => 2023-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18499248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/499248 | Ectonucleotidase inhibitors and methods of use thereof | Oct 31, 2023 | Issued |
Array
(
[id] => 19001948
[patent_doc_number] => 20240066019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => COMPOSITION FOR ENHANCING MITOCHONDRIAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/382904
[patent_app_country] => US
[patent_app_date] => 2023-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382904
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/382904 | Composition for enhancing mitochondrial function | Oct 22, 2023 | Issued |
Array
(
[id] => 19839083
[patent_doc_number] => 12251439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Inactivating bacteria with electric pulses and antibiotics
[patent_app_type] => utility
[patent_app_number] => 18/490238
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 13800
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/490238 | Inactivating bacteria with electric pulses and antibiotics | Oct 18, 2023 | Issued |
Array
(
[id] => 18902693
[patent_doc_number] => 20240018178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => NOVEL BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF AS ANTI-CANCER AGENT OR ANTI-VIRUS AGENT COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/370241
[patent_app_country] => US
[patent_app_date] => 2023-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18370241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/370241 | NOVEL BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF AS ANTI-CANCER AGENT OR ANTI-VIRUS AGENT COMPRISING THE SAME | Sep 18, 2023 | Abandoned |
Array
(
[id] => 19050985
[patent_doc_number] => 20240092954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => POLYMER THIN FILM FOR CAPTURING AND RELEASING NUCLEIC ACID WITH HIGH EFFICIENCY AND METHOD FOR EXTRACTING NUCLEIC ACID USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/452831
[patent_app_country] => US
[patent_app_date] => 2023-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18452831
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/452831 | POLYMER THIN FILM FOR CAPTURING AND RELEASING NUCLEIC ACID WITH HIGH EFFICIENCY AND METHOD FOR EXTRACTING NUCLEIC ACID USING THE SAME | Aug 20, 2023 | Pending |
Array
(
[id] => 18754158
[patent_doc_number] => 20230357542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => CELLULOSE PROCESSING
[patent_app_type] => utility
[patent_app_number] => 18/220685
[patent_app_country] => US
[patent_app_date] => 2023-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18220685
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/220685 | Cellulose processing | Jul 10, 2023 | Issued |